Biogen (BIIB) Tecfidera Patient Starts Increase 4% WoW
Tweet Send to a Friend
Biogen (NASDAQ: BIIB) Tecfidera TRx were up 1% at 6070 vs. 6,020 last week, said Deutsche Bank, citing IMS. NRx ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE